| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18f77cb53f512b9299233025a261ebe5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9071270afb4413e2261bef497e64643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67cca76e79d77d98308660ceeedd3949
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_412f339f199cd61cb8abaf6b483393e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c81705b9a47c7b1f7ee3c87eca1bb8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e310ccdd069610223bec2f586bfa4a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6896457a89bc748882b7fb459c237f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05af06ae4890e29e27163f53e3b391a4 |
| publicationDate |
2017-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170009573-A |
| titleOfInvention |
Vaccine composition for tuberculosis containing MTBK_20640 protein |
| abstract |
The present invention relates to a vaccine composition for preventing tuberculosis containing MTBK_20640 protein and a pharmaceutical composition for treating or preventing tuberculosis containing MTBK_20640 protein. The MTBK_20640 protein according to the present invention exhibits a high IFN-y production ability in the spleen and lung of an animal model causing infection by Mycobacterium tuberculosis. It can effectively prevent tuberculosis by maintaining a rapid acquired defense immunity and maintaining T cell memory have. In particular, it induces the production of multifunctional T cells known to be important for the prevention of tuberculosis in recent years. It can also be used in the treatment of tuberculosis, so it can be used to prevent recurrence or reinfection of highly pathogenic tuberculosis with high recurrence rate and to improve treatment efficiency. |
| priorityDate |
2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |